Medical experts warn about the increasing addiction risks among youth due to easy access to painkillers. Revelations from ...

Amid a reorganization campaign that’s breathed new life into hybrid generic and innovative medicines player Teva, the company ...

Improvement in some but not all domains of cognition during treatment with the atypical antipsychotic drugs clozapine, quetiapine, olanzapine, and risperidone has been reported in some but not all ...

Am J Health Syst Pharm. 2008;65(12):1180-1183. Ultimately, more formalized, high-quality, and clinically applicable studies are necessary to determine the safety of the parenteral combination of ...

An inmate at Garner Correctional Institution died in July of an overdose involving four drugs, according to the Office of the ...

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

Olanzapine is an atypical antipsychotic and was first approved by the US Food and Drug Administration in 2009 by Eli Lilly. Image credit: Jonathan Weiss / Shutterstock. Teva Pharmaceuticals has shared ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...

As mentioned supra, the lead asset in Neumora’s pipeline is Navacaprant (BTRX-335140, NMRA-140), a small molecule Kappa opioid receptor (KOR) antagonist. The drug has entered phase 3 trials for major ...